Innovotech (IOT.V) Stock Price

Innovotech Price

CLOSED
0.06
​
Market closed

Revenue has compounded at 8.8% per year over the past 19 years to 4.53 M CAD. Earnings per share have declined at 26.8% per year over the last 8 years. Innovotech's net margin stands at 2.1%, down from 24.8% several years earlier.

Innovotech stock price

Access this data via the Eulerpool API

Innovotech business model & stock analysis

Innovotech, Inc. owns, sells, and uses proprietary assay kits used in growing microbial biofilms for research purposes. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. The company also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.

Frequently asked questions about Innovotech

Converted at the current exchange rate, the Innovotech share trades at 0.04 EUR (0.06 CAD).

The revenue cannot currently be calculated for Innovotech.

The profit cannot currently be calculated for Innovotech.

The P/E ratio cannot be calculated for Innovotech at the moment.

The P/S cannot be calculated for Innovotech currently.

The Eulerpool Quality Score for Innovotech is 5/10.

The ISIN of Innovotech is CA45772U1049. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Innovotech is IOT.V. The ticker symbol is used to trade Innovotech shares on the stock exchange.

Fair ValueTerminal
0.05 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
May 28, 2003
ISIN
CA45772U1049
Cusip
45772U104
Market capitalization
3.54 M CADMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
17.10
P/B Ratio
0.98
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
2.51 %
Gross Margin
52.86 %
EBIT Margin
2.68 %
Net Margin
2.08 %
EPS (Earnings Per Share)
0.00 CAD
Net Debt / EBIT
-12.00
Debt/Equity
0.04
Last updated Oct 5, 2026, 10:02 PM

Innovotech Peer Group

Innovotech FIGI

IOT:CN · BBG000M5X6V9IOT:CV · BBG000M5X8L6IOT:CJ · BBG000M5ZG18IOT:TV · BBG000M5ZJM9IOT:TN · BBG000M5ZLB6IOT:TG · BBG000M5ZM51IOT:TK · BBG000M5ZMC3IOT:TW · BBG001QLGHX1IOT:DV · BBG003G85YB6IOT:DS · BBG004J9VM80IOT:DG · BBG005XRH4T4IOT:QF · BBG0086KCZZ2

All fundamentals and in-depth analysis of Innovotech

Our stock analysis for Innovotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.